Olanib 150 mg tablet

Olanib 150mg tablet prescription drug treatment for cancer patients in which the active substance is Olaparib – a target drug which inhibits an enzyme PARP, thereby preventing cancer cells from repairing the DNA damage.

Ovarian Cancer: Treatment of advanced or recurrent ovarian, fallopian tube, or primary peritoneal cancer.Breast Cancer: Treatment of specific forms of HER2-negative metastatic breast cancer Olanib 150mg tablet in pakistan associated with alterations in BRCA genes.Other Cancers: Also indicated for specific forms of advanced pancreatic and prostate cancers.

Regular Dose: 300 mg (2 tablets of 150 mg each) orally twice daily.Interval: 12 hours.Taking Medication: Swallow the whole tablet with water without chewing, breaking or crushing the tablets.Can be taken regardless of meal.

Olanib 150 mg (active substance Olaparib) is a prescription PARP inhibitor drug used for treating advanced or recurrent forms of specific cancers including BRCA gene mutations.

causing inhibition of cancer cells, particularly those with Olanib 150mg tablet price in pakitsan  dysfunctional DNA repair mechanisms such as BRCA1 or BRCA2 gene mutations.

Lynparza (AstraZeneca) branded drug is rarely available at common pharmacies and special measures must be undertaken for the procurement, for example,

Feeling very tired or weakNausea and stomach problemsAnemiaLowered appetite or diarrhea.